Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2010
07/07/2010CN101298454B Cephalosporin derivate containing pyrazolo triazinium
07/07/2010CN101245079B Cephalosporin antibiotic derivant
07/07/2010CN101182360B Fusion protein having antibiotic function and uses thereof
07/07/2010CN101138557B Chlorhexidine acetate partial film forming gel composition and uses thereof
07/07/2010CN100998874B IIIV vaccine containing recombination virus and its united immune preparation
07/06/2010US7750181 Antiproliferative agents
07/06/2010US7750148 chemical intermediates for making an oral antibiotics Sulbactam
07/06/2010US7749991 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization
07/06/2010US7749971 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin, optionally in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy
07/06/2010US7749970 Application of an azalide antibiotic such as azithromycin
07/06/2010US7749753 modulation of transport proteins in biological cells; genetic engineering; antibodies
07/06/2010US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators
07/06/2010US7749745 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine
07/06/2010US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta
07/06/2010US7749718 Method for raising or isolating an antibody to DCRS5
07/06/2010US7749510 Episome for transfer and expression of heterologous nucleotide sequences in gram positive bacteria; genetic vaccines
07/06/2010US7749506 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans
07/06/2010US7749502 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis
07/06/2010US7749499 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics
07/06/2010CA2460222C Eustachian tube stent
07/06/2010CA2446149C Vitamin d analogues
07/06/2010CA2395419C Agent for the anti-adhesion of skin pathogenic flora
07/06/2010CA2359462C Pyrazole compounds and uses thereof
07/06/2010CA2328056C Attenuated mutants of salmonella which constitutively express the vi antigen
07/01/2010WO2010075554A1 Synthesis of purine nucleosides
07/01/2010WO2010075477A2 Methods of treating or preventing biofilm associated infections with free available chlorine water
07/01/2010WO2010075416A1 Antibiotic compositions for the treatment of gram negative infections
07/01/2010WO2010075380A1 Anti-viral compounds
07/01/2010WO2010075376A2 Anti-viral compounds
07/01/2010WO2010075127A1 Antiviral compounds
07/01/2010WO2010075101A2 Treating picornavirus infection by targeting microrna mir-141
07/01/2010WO2010074284A1 Pyrazolopyrimidine compound
07/01/2010WO2010074126A1 Recombinant avian-infectious coryza vaccine and method for producing same
07/01/2010WO2010073825A1 Antibacterial composition and antiviral composition each containing silicon-containing compound, antibacterializing method, cleaning/mouth cleaning method, and method for immobilizing antibacterial agent or antiviral agent
07/01/2010WO2010073647A1 Human anti-human influenza virus antibody
07/01/2010WO2010073642A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
07/01/2010WO2010073257A1 An immunodominant b-cell epitope based protein vaccine against anthrax and method of preparation thereof
07/01/2010WO2010073235A1 Ppar agonist compositions and methods of use
07/01/2010WO2010073204A1 Anti-hcv monoclonal antibody as a medicament for the therapeutic treatment and prevention of hcv infections
07/01/2010WO2010073043A1 Immunogenic composition and use thereof
07/01/2010WO2010072813A1 Competitive inhibitors of type ii dehydroquinase enzyme
07/01/2010WO2010072770A2 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
07/01/2010WO2010072684A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity
07/01/2010WO2010072672A1 New crystal polymorphs of ceftobiprole
07/01/2010WO2010072598A1 Heterocyclic antiviral compounds
07/01/2010WO2010072399A1 7-azaindirubins, 7'azaindirubins, 7,7'-diazaindirubins and the corresponding 3'-oxime ether derivatives thereof, their production and use as a medicament
07/01/2010WO2010072352A1 1, 2, 4 -oxadiazole derivatives and their therapeutic use
07/01/2010WO2010072155A1 Pyrimidine derivative, preparation method and use thereof
07/01/2010WO2010072050A1 Use of forsythoside a in manufacture of medicaments for treating hepatitis b
07/01/2010WO2010071986A1 Modified steptococcus pneumonia pneumolysin (ply) polypeptides
07/01/2010WO2010071941A1 Plant extracts from acronychia species and their use
07/01/2010WO2010046912A3 Thiophene containing analogues of fluconazole as antifungal agents and process for their preparation
07/01/2010WO2010046461A3 Treatment of intracellular bacterial infections
07/01/2010WO2010045381A3 Antimicrobial agents that target bacterial vkor
07/01/2010WO2010041279A3 Sustained release drug delivery system
07/01/2010WO2010039563A3 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens
07/01/2010WO2010028306A3 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions
07/01/2010US20100168685 Serially Dispensable Antiseptic Wet Wipes Moistened with Tincture of Green Soap
07/01/2010US20100168233 Terbinafine formulation
07/01/2010US20100168225 Small-Molecule Hepatitis C Virus (HCV) NS3/4A Serine Protease Inhibitors
07/01/2010US20100168221 Pharmaceutical composition for treating hepatitis b virus and health food product having hepatitis b virus inhibiting effects
07/01/2010US20100168220 Plant extract composition for treating hepatitis c
07/01/2010US20100168210 T-Cell Cytokine-Inducing Surface Molecules and Methods of Use
07/01/2010US20100168205 Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules
07/01/2010US20100168203 Adenylyl cyclases as novel targets for antibactrial interventions
07/01/2010US20100168190 Novel azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (nnrtis) in antiviral therapy (hiv)
07/01/2010US20100168176 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
07/01/2010US20100168173 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
07/01/2010US20100168169 Substituted 1,3-dioxanes useful as ppar modulators
07/01/2010US20100168144 Inhibitors of protein kinases
07/01/2010US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta
07/01/2010US20100168138 Anti-Viral Compounds
07/01/2010US20100168133 Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
07/01/2010US20100168115 Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect
07/01/2010US20100168104 Hiv inhibiting 5-amido substituted pyrimidines
07/01/2010US20100168098 Viral Polymerase Inhibitors
07/01/2010US20100168097 Non-Nucleoside Reverse Transcriptase Inhibitors
07/01/2010US20100168063 Bicyclic pyrimidinones and uses thereof
07/01/2010US20100168057 Fungal growth inhibitor
07/01/2010US20100168053 Oral delivery system for methylcobalamin to treat disorders
07/01/2010US20100168052 Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation
07/01/2010US20100168046 Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases
07/01/2010US20100168032 Smart Pro-Drugs of Serine Protease Inhibitors
07/01/2010US20100168004 Methods and compositions for the synergistic activation of latent hiv
07/01/2010US20100168002 Therapeutic peptides
07/01/2010US20100167998 Growth-stimulating polypeptides for use in fish and crustaceans
07/01/2010US20100167996 3-Ether and 3-Thioether Substituted Cyclosporin Derivatives For the Treatment and Prevention of Hepatitis C Infection
07/01/2010US20100167995 Peptoid compounds
07/01/2010US20100167992 Phenyl Ester Side Chains to Increase Polymer Resorptivity
07/01/2010US20100167393 Modified human thymic stromal lymphopoietin
07/01/2010US20100167377 Recombinant viruses comprising the membrane-proximal domain of VSV G protein
07/01/2010US20100167352 Infectious clones
07/01/2010US20100166898 Anti-bacterial use of extract from morus australis poir. and compound kuwanon h
07/01/2010US20100166874 Technology for Preparation of Macromolecular Microspheres
07/01/2010US20100166826 Biodegradable intravaginal devices for delivery of therapeutics
07/01/2010US20100166809 Methods of treating or preventing biofilm associated infections with free available chlorine free available chlorine water
07/01/2010US20100166806 Combination therapy comprising the use of protein kinase C modulators and Histone Deacetylase inhibitors for treating HIV-1 latency
07/01/2010US20100166801 Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis
07/01/2010US20100166800 Recombinant attenuated clostridium organisms and vaccine
07/01/2010US20100166798 Method and kit for treatment/prevention of hair loss
1 ... 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 ... 1798